Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6139276 | 0.91 | TDP1 (0.72) | TDP1TSHRHRH3NPC1RAB9A | |
| SCHEMBL293649 | 0.85 | TDP1 (0.81) | TDP1TSHRNPC1RAB9AKMT2A | |
| SCHEMBL809590 | 0.80 | TDP1 (0.62) | TDP1TSHRNPC1RAB9AKMT2A | |
| SCHEMBL18869077 | 0.80 | TDP1 (0.53) | TDP1TSHRNPC1RAB9AKMT2A | |
| SCHEMBL9860144 | 0.79 | TDP1 (0.79) | TDP1TSHRNPC1RAB9AKMT2A | |
| SCHEMBL6912197 | 0.79 | LMNA (0.64) | TDP1TSHRRAB9AALDH1A1MAPT | |
| SCHEMBL2566452 | 0.79 | TDP1 (1.00) | TDP1TSHRNPC1RAB9AKMT2A | |
| SCHEMBL27296364 | 0.78 | PARP10 (0.57) | HRH3MAPK1GAA | |
| SCHEMBL8755014 | 0.78 | HPGD (0.49) | TDP1TSHRHRH3NPC1RAB9A | |
| SCHEMBL7804270 | 0.78 | MEN1 (0.53) | HRH3KMT2AALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105120900-A | Compositions and methods for treating chronic inflammation and inflammatory diseases | INFIRST HEALTHCARE LTD | 2015-12-02 | — | — | CN | claimed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | claimed |
| US-20040147606-A1 | SYNERGISTIC MIXTURE OF FUDOSTEINE AND ANALGESICS, ANTIPYRETICS | SSP CO., LTD. (JP) | 2004-07-29 | — | — | US | claimed |
| EP-1391201-A1 | MEDICINAL COMPOSITIONS | SSP Co., Ltd. (JP) | 2004-02-25 | — | — | EP | claimed |
| JP-56115719-A | — | — | None | — | — | JP | disclosed |
| EP-4692178-A1 | CELLULOSE POWDER AND MOLDED BODY | Asahi Kasei Kabushiki Kaisha (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12427113-B2 | Cellulose composition, tablet, and orally disintegrating tablet | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-30 | — | — | US | disclosed |
| WO-2025121315-A1 | CELLULOSE POWDER AND MOLDED BODY | 旭化成株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025105451-A1 | SOLID PREPARATION | 第一三共ヘルスケア株式会社 | 2025-05-22 | — | — | WO | disclosed |
| WO-2025100523-A1 | METHOD FOR PRODUCING SOLID PREPARATION, AND TABLETS | 第一三共ヘルスケア株式会社 | 2025-05-15 | — | — | WO | disclosed |
| WO-2025100462-A1 | SOLID COMPOSITION CONTAINING BROMHEXINE | 第一三共ヘルスケア株式会社 | 2025-05-15 | — | — | WO | disclosed |
| US-12290602-B2 | Cellulose powder, use thereof, and tablets | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-05-06 | — | — | US | disclosed |
| EP-0631782-B1 | Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-05-06 | — | — | EP | disclosed |
| US-5726180-A | CAFFEINE, DEXTROMETHORPHAN, PHENYLPROPANOLAMINE, IBUPROFEN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| US-5629316-A | Stabilized solid pharmaceutical preparation and method of producing the same | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0631782-A1 | Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine | Takeda Chemical Industries, Ltd. (JP) | 1995-01-04 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
| JP-S56115719-A | ANTIPYRETIC, ANALGESIC, AND ANTIPHLOGISTIC AGENT | LION CORP | 1981-09-11 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, CTSA, ALG1 | TDP1 971/4885TSHR 3963/4885HRH3 4704/4885 |
| US-20040147606-A1 | SYNERGISTIC MIXTURE OF FUDOSTEINE AND ANALGESICS, ANTIPYRETICS | PTGES, CCL11, UROD | TDP1 3108/4885TSHR 4617/4885HRH3 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.